Technology-enabled remote monitoring for chronic obstructive pulmonary disease (COPD)

Close up of a person using an inhaler next to an image of an oxygen monitor on a person's finger, photos by DALU11 and Microgen/Adobe Stock

Photos by DALU11 and Microgen/Adobe Stock

Chronic obstructive pulmonary disease (COPD) is a common, treatable and largely preventable lung condition. Approximately 3 million people in the UK are living with COPD and its exacerbations are the second largest cause of hospital admissions. Timely identification of patients at risk of deterioration is crucial to its successful management, as is access to pulmonary rehabilitation (education and physical exercise programmes) and self-management tools (helping patients understand and track their symptoms and disease progression; supporting behaviour change and medication adherence). Technology-enabled remote monitoring, such as using devices to monitor a patient’s health (e.g. oxygen saturation or inhaler adherence) and digital applications to record patient clinical data in their own home and share it electronically with a health professional, is one of the potential means to support patients in managing COPD and to improve their experience of care and outcomes.

What is the issue?

Current examples of technology-enabled remote monitoring in the COPD care pathway range from the use of smart inhalers to apps digitally facilitating virtual pulmonary rehabilitation to dedicated care hubs (staffed by a health professional) providing 24-hour proactive remote monitoring. However, despite the potential of technology-enabled remote monitoring in COPD management, key gaps remain in the evidence on how to effectively implement COPD care pathways that are enabled by technology. It is also not fully known what approaches work in which contexts and for whom, what the implications are for patients, carers and the health workforce, and how to ensure that the approaches help with addressing inequalities and do not exacerbate them.

There is widespread interest in technology-enabled remote monitoring for COPD, demonstrated by a diverse and quickly evolving landscape of healthcare and technology providers and pilot, testing and implementation projects in the UK. Such examples of implementation offer valuable insights into real-world applications of technology-enabled service provision for patients with COPD, its impact and how such technology may become more systematically and effectively embedded within respiratory care pathways.

How did we help?

DECIDE (Digitally Enabled Care in Diverse Environments) is a centre for rapid evaluation of technology-enabled remote monitoring in health and care, funded by the National Institute for Health and Care Research Health and Social Care Delivery Research (NIHR HSDR). DECIDE is a partnership between the University of Oxford and RAND Europe.

The DECIDE centre conducted a rapid evaluation to inform decision making around technology-enabled remote monitoring for COPD. The NHS England LungHealth@Home team was the policy customer for this work. The aim was to gain a deeper understanding of technology-enabled remote monitoring of patients living with COPD, and generate transferable lessons on the resources, systems, people, interactions, roles, behaviours and structures needed to achieve sustained adoption at scale. The findings should be helpful for informing policy decisions at a national level, support local system improvement and implementation, as well as be of wider interest to charities, diverse populations and scholars from a wide range of disciplines.

The rapid evaluation unfolded in three core phases

  1. A rapid literature review of the current evidence base on the implementation and impact of tech-enabled remote monitoring pathways for COPD.
  2. Case studies based on desk research, interviews and workshops to learn from efforts to implement technology-enabled remote monitoring for COPD.
  3. Development of user-friendly, co-designed, patient-facing resources to help patients navigate tech-enabled remote monitoring pathways.

What did we find?

  • Evidence for clinical effectiveness, long-term outcomes, equity and cost-effectiveness of technology-enabled remote monitoring for patients with COPD remains limited. While prior research suggests some potential benefits (e.g. reduced hospitalisations in some contexts), the overall evidence base remains incomplete and inconclusive.
  • Technology-enabled remote monitoring for COPD is used in very different ways depending on context. This can range from light-touch self-management, hybrid models combining patient self-management with clinician oversight, to proactive monitoring with regular check-ins and case-management by clinicians.
  • Implementation success depends strongly on organisational readiness and clear purpose. A clear value proposition, efforts to secure buy-in from all stakeholders and to organise the workforce and workload sustainably, alongside technical determinants such as interoperability of IT platforms, and support for patients to safely and appropriately use the service are key.
  • The perceived value of these pathways has common and unique aspects for patients and healthcare staff. For patients, remote monitoring can help patients feel more connected with healthcare providers and give a sense of reassurance at home. Clinicians and service providers emphasised the importance of balancing high-quality care with affordability, sustainable workload impact, and maintaining safety and oversight. They noted that remote monitoring services should complement existing care pathways rather than replacing them.

What are our recommendations?

  • Embed technology within whole-pathway COPD care, not as a stand-alone solution. Purposeful technology can support remote monitoring but is only one aspect of an effective service. Technology has to align with the local service needs and staff capacity, with proportionate oversight of quality and safety. Tech-enabled services should prioritise essential functionalities and avoid introducing tools that are unnecessary or unsupported.
  • Support patients to be able to effectively engage with the service, to mitigate against inequalities in access. For example, different patients can have varying levels of digital literacy or access to devices and may need different types of support to be able to engage effectively. Co-designed educational resources, clear communication, and options for non-digital service pathways need to be considered, so that those who cannot engage digitally can access the services they need in more traditional ways (e.g. face-to-face meetings, telephone appointments).
  • Design remote monitoring as a flexible service that adapts to patient needs over time. Remote monitoring services covers a spectrum of intervention types and intensities, rather than a single approach. Services need to clearly define what is included, offer all eligible patients the opportunity to participate, provide appropriate onboarding and early follow-up, and be able to adapt to changing patient needs.
  • Enable a coordinated research agenda and shared learning. Robust mixed-method evaluations and patient-centred insights are needed to generate evidence on the most effective use of remote monitoring for COPD. This includes establishing the needed data infrastructure to enable evaluation with clear indicators for patient outcomes, service utilisation and cost-effectiveness, supporting context-sensitive and comparative study designs, integrating patient and caregiver perspectives and establishing communities of practice to share learning.

Project Team at RAND Europe

  • Agnė Ulytė 271681

    Agne Ulyte

    Senior Analyst

  • JO ANTHONY

    Sonja Marjanovic

    Director, Healthcare Innovation, Industry and Policy, RAND Europe

  • ZM

    Zuzanna Marciniak-Nuqui

Collaborators at University of Oxford

  • Dr. Nikki Newhouse. Photo courtesy of Nikki Newhouse

    Dr. Nikki Newhouse

  • Professor Sara Shaw. Photo courtesy of Sara Shaw

    Professor Sara Shaw

  • Dr. Jackie Van Dael

    Dr. Jackie Van Dael